143 related articles for article (PubMed ID: 10882574)
1. Poliovirus-specific intestinal antibody responses coincide with decline of poliovirus excretion.
Valtanen S; Roivainen M; Piirainen L; Stenvik M; Hovi T
J Infect Dis; 2000 Jul; 182(1):1-5. PubMed ID: 10882574
[TBL] [Abstract][Full Text] [Related]
2. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus.
Herremans TM; Reimerink JH; Buisman AM; Kimman TG; Koopmans MP
J Immunol; 1999 Apr; 162(8):5011-8. PubMed ID: 10202050
[TBL] [Abstract][Full Text] [Related]
3. Serotype-specific mucosal immune response and subsequent poliovirus replication in vaccinated children.
Samoilovich E; Roivainen M; Titov LP; Hovi T
J Med Virol; 2003 Oct; 71(2):274-80. PubMed ID: 12938203
[TBL] [Abstract][Full Text] [Related]
4. Effect of different vaccination schedules on excretion of oral poliovirus vaccine strains.
Laassri M; Lottenbach K; Belshe R; Wolff M; Rennels M; Plotkin S; Chumakov K
J Infect Dis; 2005 Dec; 192(12):2092-8. PubMed ID: 16288372
[TBL] [Abstract][Full Text] [Related]
5. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.
Abbink F; Buisman AM; Doornbos G; Woldman J; Kimman TG; Conyn-van Spaendonck MA
J Infect Dis; 2005 Mar; 191(6):990-9. PubMed ID: 15717277
[TBL] [Abstract][Full Text] [Related]
6. Nasopharyngeal secretory antibody response to poliovirus type 3 virion proteins exhibit different specificities after immunization with live or inactivated poliovirus vaccines.
Zhaori G; Sun M; Faden HS; Ogra PL
J Infect Dis; 1989 Jun; 159(6):1018-24. PubMed ID: 2470831
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants.
Asturias EJ; Dueger EL; Omer SB; Melville A; Nates SV; Laassri M; Chumakov K; Halsey NA
J Infect Dis; 2007 Sep; 196(5):692-8. PubMed ID: 17674310
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and fecal poliovirus excretion in sequential use of inactivated and oral poliovirus vaccines.
Lu CY; Kao CL; Lee CY; Lee PI; Huang LM
J Formos Med Assoc; 2001 Aug; 100(8):513-8. PubMed ID: 11678000
[TBL] [Abstract][Full Text] [Related]
9. Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.
Swartz TA; Green MS; Handscher R; Sofer D; Cohen-Dar M; Shohat T; Habib S; Barak E; Dror Z; Somekh E; Peled-Leviathan T; Yulzari R; Libling A; Mendelson E; Shulman LM
Vaccine; 2008 Feb; 26(8):1083-90. PubMed ID: 18241962
[TBL] [Abstract][Full Text] [Related]
10. Mucosal immunity induced by enhance-potency inactivated and oral polio vaccines.
Onorato IM; Modlin JF; McBean AM; Thoms ML; Losonsky GA; Bernier RH
J Infect Dis; 1991 Jan; 163(1):1-6. PubMed ID: 1845806
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses.
Faden H; Modlin JF; Thoms ML; McBean AM; Ferdon MB; Ogra PL
J Infect Dis; 1990 Dec; 162(6):1291-7. PubMed ID: 2172403
[TBL] [Abstract][Full Text] [Related]
12. Anomalous observations on IPV and OPV vaccination.
John TJ
Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
[TBL] [Abstract][Full Text] [Related]
13. Antibody response of children immunized with poliovaccines: an evaluation using two strains of poliovirus type 1.
Deshpande JM; Dave KH
Indian J Med Res; 1992 Sep; 95():216-20. PubMed ID: 1335965
[TBL] [Abstract][Full Text] [Related]
14. Comparison of serum and salivary antibodies in children vaccinated with oral live or parenteral inactivated poliovirus vaccines of different antigen concentrations.
Zaman S; Carlsson B; Jalil F; Mellander L; Van Wezel AL; Böttiger M; Hanson LA
Acta Paediatr Scand; 1991 Dec; 80(12):1166-73. PubMed ID: 1785289
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of trypsin treated type 2 and type 3 poliovirus in rats.
Kersten GF; Lantinga M; Hazendonk T; Beuvery EC
Biologicals; 1995 Jun; 23(2):179-83. PubMed ID: 7546661
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin a as a serological marker for the (silent) circulation of poliovirus in an inactivated poliovirus-vaccinated population.
Herremans T; Kimman TG; Conyn-Van Spaendonck MA; Buisman A; de Melker H; Abbink F; Bijkerk P; Koopmans MP
Clin Infect Dis; 2002 Apr; 34(8):1067-75. PubMed ID: 11914995
[TBL] [Abstract][Full Text] [Related]
17. The humoral immune response to type 1 oral poliovirus vaccine in children previously immunized with enhanced potency inactivated poliovirus vaccine or live oral poliovirus vaccine.
Modlin JF; Onorato IM; McBean AM; Albrecht P; Thoms ML; Nerhood L; Bernier R
Am J Dis Child; 1990 Apr; 144(4):480-4. PubMed ID: 2157337
[TBL] [Abstract][Full Text] [Related]
18. Intestinal immunity is a determinant of clearance of poliovirus after oral vaccination.
Wright PF; Wieland-Alter W; Ilyushina NA; Hoen AG; Arita M; Boesch AW; Ackerman ME; van der Avoort H; Oberste MS; Pallansch MA; Burton AH; Jaffar MA; Sutter RW
J Infect Dis; 2014 May; 209(10):1628-34. PubMed ID: 24459191
[TBL] [Abstract][Full Text] [Related]
19. Determination of poliovirus-specific IgA in saliva by ELISA tests.
Ivanov A; Dragunsky E; Ivanova O; Rezapkin G; Potapova S; Chumakov K
J Virol Methods; 2005 Jun; 126(1-2):45-52. PubMed ID: 15847918
[TBL] [Abstract][Full Text] [Related]
20. Intestinal IgA neutralizing antibodies in newborn infants following poliovirus immunization.
Keller R; Dwyer JE; Oh W; D'Amodio M
Pediatrics; 1969 Mar; 43(3):330-8. PubMed ID: 4180265
[No Abstract] [Full Text] [Related]
[Next] [New Search]
